A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined with Alemtuzumab as Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908)

Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) patients requiring initial therapy are often older and frailer and unsuitable candidates for standard chemoimmunotherapy regimens. Shorter duration combination monoclonal antibody (mAb) therapy using alemtuzumab and rituximab has been sho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Hematol
Autors principals: Zent, Clive S., Wang, Xin Victoria, Ketterling, Rhett P., Hanson, Curtis A., Libby, Edward N., Barrientos, Jacqueline C., Call, Timothy G., Chang, Julie E., Liu, Jane J., Calvo, Alejandro R., Lazarus, Hillard M., Rowe, Jacob M., Luger, Selina M., Litzow, Mark R., Tallman, Martin S.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4806550/
https://ncbi.nlm.nih.gov/pubmed/26662208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24265
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars